patial Genomics & Transcriptomics Market Deep Research Report with Forecast to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Spatial Genomics & Transcriptomics Market- (By Technique (Spatial Transcriptomics (Immunohistochemistry (IHC), In Situ Hybridization, Sequencing Techniques (Microdissection-based sequencing, In situ sequencing), Microscopy based RNA imaging, Other Spatial Transcriptomics Techniques), Spatial Genomics Analysis (FLUORESCENCE In Situ Hybridization, Sequencing Techniques, Other Spatial Genomics Analysis Techniques)), By Product (Instruments, Consumables, Software), By Application (Translational Research, Drug Discovery and Development), By End-User (Academic and Research Institutes, Contract Research Organization, Pharmaceutical and Biotechnology Companies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Spatial Genomics & Transcriptomics Market is valued at US$ 238.84 Mn in 2022, and it is expected to reach US$ 667.51 Mn by 2031, with a CAGR of 12.3% during a forecast period of 2023-2031.

Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2023

Transcriptomics investigates gene appearance patterns, whereas genomics provides an overview of the entire set of genetic directives provided by DNA. The study of all genes and their related mRNAs is known as genomics and transcriptomics. Spatial genomics and transcriptomics are innovative tools that bridge the gap between genomics and tissue biology. They offer a new dimension of information by revealing how genes and transcripts are organized and expressed within the spatial context of tissues and cells, opening up new avenues for research in various fields, including developmental biology, disease research, and drug discovery.

The adoption of spatial genomics and transcriptomics technologies is driving the development of the spatial genomics & transcriptomics market, owing to their various applications such as stem cell and cancer research, tissue-specific gene expression studies, embryogenesis and in-vitro fertilization, and characterization of non-coding RNAs, among others. Furthermore, the rising prevalence of genetic illnesses, the use of spatial genomics and transcriptomics in the identification of disease and treatment markers, and the growing preference for personalized medications all contribute to the market's expansion.

List of Prominent Players in the Spatial Genomics & Transcriptomics Market:
• 10x Genomics
• NanoString Technologies
• Illumina
• Fluidigm Corporation
• PerkinElmer
• Akoya Biosciences (formerly known as CytoViva)
• Spatial Transcriptomics
• Dovetail Genomics (Part of Illumina)
• S2 Genomics
• Visiopharm
• MGI Tech Co. Ltd.
• CARTANA
• RareCyte
• Horizon Discovery Group
• IONpath

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2023

Market Dynamics:

Drivers-
Spatial genomics and transcriptomics have evolved from solely research applications to drug discovery and development applications in recent years. Genomics and transcriptomics are powerful tools for speeding up drug discovery and development. Spatial approaches are currently being used to better understand infectious diseases. Spatial Genomics & Transcriptomics applications are developing over time, with the goal of gaining insights into neurodegenerative illnesses and cancer. One of the key unmet therapeutic requirements in oncology is the need for predictive indicators of response, which spatial genomics and transcriptomics are expected to provide. These biomarkers aid in the development of immunotherapies by providing a better understanding of the tumour microenvironment.

Challenges:
Inadequate knowledge of the underlying scientific principles and technique selection may result in various direct and indirect costs, increasing the workload and time pressure on researchers and service providers. As a result, highly qualified employees are required for method development, validation, operation, and troubleshooting tasks. Lack of clarity on transcriptome research outcomes, combined with high equipment costs, has resulted in lesser adoption of transcriptomic technologies, limiting the spread of technical knowledge linked to transcriptomics research.

Regional Trends:
The North American spatial Genomics & Transcriptomics Market is expected to record a maximum market share in terms of revenue, and it is projected to grow at a high CAGR in the near future due to the increasing usage of technologies for spatial profiling in cancer research, along with a rising focus on genomics-based R&D. The increased investment in the region by both government and private firms contributes to the overall market's growth. The majority is ascribed to enormous investments in cancer research to meet the strong demand in the United States for new diagnostic and treatment technologies. Moreover, The Asia-Pacific region sets a high value on healthcare and biomedical research. Spatial genomics and transcriptomics were used to investigate diseases, biomarkers, and personalized medicine techniques.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/2023

Recent Developments:
• In May 2023, 10x Genomic Launched the Visium CytAssist Gene and Protein Expression Assay. Visium CytAssist Gene and Protein Expression made it possible for researchers to map together highly multiplexed protein data and whole transcriptome RNA data from the same formalin-fixed, paraffin-embedded (FFPE) tissue cut at high spatial resolution.

• In April 2023, Bio-Techne and Lunaphore announced a collaboration to create the world's first automated spatial omics multi-workflow. The technology will be built to provide complete panel design flexibility.

Segmentation of Spatial Genomics & Transcriptomics Market-
By Technique-
• Spatial Transcriptomics
o Immunohistochemistry (IHC)
o In Situ Hybridization
o Sequencing Techniques
 Microdissection-based sequencing
 In situ sequencing
o Microscopy-based RNA imaging
o Other Spatial Transcriptomics Techniques
• Spatial Genomics Analysis
o FLUORESCENCE In Situ Hybridization
o Sequencing Techniques
o Other Spatial Genomics Analysis Techniques
By Product-
• Instruments
• Consumables
• Software
By Application-
• Translational Research
• Drug Discovery and Development
By End-User-
• Academic and Research Institutes
• Contract Research Organization
• Pharmaceutical and Biotechnology Companies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

For More Information: https://www.insightaceanalytic.com/report/spatial-genomics--transcriptomics-market/2023

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
loaction icon
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email iconinfo@insightaceanalytic.com
call icon
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
Dhanraj Zurange
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.